The Department of Justice filed an antitrust lawsuit against NewYork-Presbyterian, alleging the hospital used “all-or-nothing” contracts that blocked lower-cost plans and limited competition. The case ...

An NYU Stern report links private equity in healthcare to worse outcomes and higher bankruptcy risk, calling for reforms and stronger oversight.

Internal medicine physician Dr. Missy Scalise can recall the darkest day of her career vividly. “I was taking my son to his five year-old annual physical and the doctor was asking him the typical sort ...

TeamHealth, a physician-led practice, and Array Behavioral Care, a virtual psychiatry and therapy practice, have partnered in an effort to improve emergency mental health care, the companies shared ...

Affordability is top of mind for executives at AHIP as Americans battle skyrocketing healthcare costs. “We are laser-focused on affordability at AHIP,” said Mike Tuffin, president and CEO of AHIP.

A Bayer drug designed to target tumors driven by a rare genetic mutation now has accelerated FDA approval, providing another treatment option for certain patients with advanced cases of lung cancer.

Matching a drug to a patient’s biology is not a new idea, but it hasn’t caught on in neuropsychiatric disorders, which have high failure rates in drug studies. The technology of Alto Neuroscience ...

At Wayne General Hospital in rural Mississippi, clinicians say AI-powered stethoscope usage is helping them detect heart problems earlier in patients who often have limited access to specialists. The ...

Bispecific antibodies are one of the most active areas of cancer research, and pharmaceutical companies are busy striking deals to add them to their pipelines. One of the most talked about drugs at ...

Sarepta Therapeutics’ report of a second fatality this year in a patient dosed with its Duchenne muscular dystrophy gene therapy raised the prospect it might have to pull the product from the market.

The FDA has approved a pill version of Novo Nordisk’s blockbuster drug Wegovy, giving the company the lead in the pharmaceutical industry pursuit of oral weight loss drugs while also providing ...